Abstract
Introduction Eggs offer a range of essential nutrients that could potentially support skeletal health as individuals age. Maintaining bone density is crucial for reducing the risk of fractures and improving overall mobility and quality of life in later years. Understanding the potential benefits of habitual egg consumption on bone mass density among older people is essential, given that the natural decline in bone mass density occurs with age. This area of research has not garnered sufficient attention basically because of the mixed reactions and conflicting reports about the safety of egg consumption especially among the elderly hence the scoping review aims to systematically examine the existing literature to map the evidence regarding the association between habitual egg consumption and bone mass density in elderly individuals.
Methodology The scoping review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines to ensure methodological rigor and transparency. Five electronic databases were searched for published pieces of literature. The review included letters, reviews, observational studies, and experimental studies, while the exclusion criteria were books, grey literature, and publications not in English.
Results Out of an initial 315 studies found across five databases, 27 duplicates were removed. After screening, 283 studies were excluded as they did not meet the study eligibility criteria. Only two studies were finally included in the review, with two excluded due to focusing on eggshell powder’s impact on elderly bone mass and one involving children.
Conclusion Limited research on the link between egg consumption and bone mass density in the elderly highlights the need for further investigation. Concerns about cholesterol have overshadowed potential benefits. Given aging populations and bone health challenges, exploring eggs’ role in preventing falls and fractures is essential for a proactive approach to elderly well-being.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Available in the manuscript
